As AI agents mature, the question becomes: what is the human for?

Contributor(s): Dr Nick Lynch & Dr Raminderpal Singh

In part II of his conversation with Dr Nick Lynch, founder of Curlew Research, Raminderpal Singh asks the uncomfortable questions that we may not yet be equipped to answer – or ready to face.

As AI agents move from demos into real drug-discovery workflows, the question that underpins all others gets harder to avoid: what is the human actually for, once the agents become capable?

Dr Nick Lynch is not a hype merchant on this subject. He spent over 13 years at AstraZeneca, served as a co-founder at the Pistoia Alliance and now runs the data and informatics strategy consultancy Curlew Research. Having witnessed enough technology cycles to be wary of both the doom and the evangelism, he offers a fairly practical model of how mixed teams of people and AI agents might actually work and where the limits sit.